NEPA to Prevent Chemotherapy Induced Nausea and Vomiting in Patients With Breast Cancer
Status:
Completed
Trial end date:
2017-04-03
Target enrollment:
Participant gender:
Summary
This study evaluates if the activity of one-day of NEPA plus dexamethasone, to prevent
chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant
AC-based chemotherapy, is maintained during all the chemotherapy cycle treatment (maximum 4
cycles).